ArticleOncology letters2018

Erythropoietin-producing hepatocellular A6 overexpression is a novel biomarker of poor prognosis in patients with breast cancer.

Danmei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.